Effects of treatment with premarin and clobetasol-premarin in vaginal disease after hematopoietic stem cell transplantation.

Phase 3

Recruiting

• Conditions: Condition 1: Graft-versus-host disease (GVHD). Condition 2: Hematopoietic stem cell transplantation.; Graft-versus-host disease; Complications of stem cell transplant; D89.81; T86.5

• Registration Number: IRCT20160615028486N3
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 55

Inclusion Criteria

Female patients undergoing bone marrow transplantation
Consent to participate in research

Exclusion Criteria

History of cervical cancer
History of uterine,cervical,vaginal congenital anomaly
Patient disagreement

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vaginal involvement of graft-versus-host disease. Timepoint: 1 year. Method of measurement: Gynecology examination.